NP49425 Generic and Biosimilar Transition Medicines

Description

Supply of generic and biosimilar transition medicines to NHS Scotland. Lot 1: Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) Supply of cytokine modulators (golimumab, tocilizumab, and etanercept) to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published. Lot 2: Cytokine Modulators (Omalizumab) Supply of cytokine modulators (omalizumab) to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published. Lot 3: Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines Supply of gastrointestinal, endocrine, blood, and multiple sclerosis medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published. Lot 4: Denosumab (Osteoporosis) and Ferric Carboxymaltose Supply of denosumab (osteoporosis) and ferric carboxymaltose to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published. Lot 5: Apremilast Supply of apremilast to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published. Lot 6: Cardiovascular and Respiratory Medicines Supply of cardiovascular and respiratory medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published. Lot 7: Nintedanib Supply of nintedanib to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published. Lot 8: Cancer Medicines (Group 1) Supply of cancer medicines (group 1) to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published. Lot 9: Cancer Medicines (Group 2) Supply of cancer medicines (group 2) to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published. Lot 10: Psychiatry and Neurology Medicines Supply of psychiatry and neurology medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.